BCYC BICYCLE THERAPEUTICS plc

  1. Stocks
  2. Healthcare
  3. NASDAQ: BCYC

Price (delayed)

$3.6

Market cap

$251.97M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$2.73

Enterprise value

-$244.4M

?
Relative Growth: Rel. Growth: 66
Relative Strength: Rel. Strength: 14
Relative Valuation: Rel. Valuation: 13
Relative Profitability: Rel. Profitability: 35
Highlights
BICYCLE THERAPEUTICS's EPS has increased by 22% YoY and by 13% from the previous quarter
BCYC's net income is up by 21% YoY and by 13% QoQ
BICYCLE THERAPEUTICS's quick ratio has increased by 16% YoY but it has decreased by 4.7% QoQ
BCYC's equity is down by 24% year-on-year and by 8% since the previous quarter
BICYCLE THERAPEUTICS's gross profit has decreased by 3.6% QoQ
Sector: Healthcare
Industry: Biotechnology
Website: http://www.bicycletherapeutics.com
Peers: OLMA OMER VIVS ORIC

Key stats

What are the main financial stats of BCYC

BCYC stock price

How has the BICYCLE THERAPEUTICS stock price performed over time
Intraday
-3.49%
1 week
-1.1%
1 month
-17.62%
1 year
-49.22%
YTD
-49.15%
QTD
-15.09%

Financial performance

How have BICYCLE THERAPEUTICS's revenue and profit performed over time
Revenue
$61.21M
Gross profit
$61.21M
Operating income
-$210.3M
Net income
-$190.41M
Gross margin
100%
Net margin
-311.1%
The operating margin has soared by 77% YoY and by 10% from the previous quarter
BCYC's net margin has soared by 75% year-on-year and by 10% since the previous quarter
The operating income rose by 27% year-on-year and by 13% since the previous quarter
BCYC's net income is up by 21% YoY and by 13% QoQ

Price vs fundamentals

How does BCYC's price correlate with its fundamentals

Growth

What is BICYCLE THERAPEUTICS's growth rate over time

Valuation

What is BICYCLE THERAPEUTICS stock price valuation
P/E
N/A
P/B
0.49
P/S
4.11
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
-3.99
BICYCLE THERAPEUTICS's EPS has increased by 22% YoY and by 13% from the previous quarter
The stock's P/B is 77% below its 5-year quarterly average of 2.2 and 27% below its last 4 quarters average of 0.7
BCYC's equity is down by 24% year-on-year and by 8% since the previous quarter
The P/S is 89% less than the 5-year quarterly average of 39.1 and 52% less than the last 4 quarters average of 8.9
BCYC's revenue is down by 3.6% QoQ

Efficiency

How efficient is BICYCLE THERAPEUTICS business performance
BICYCLE THERAPEUTICS's ROS has soared by 76% YoY and by 10% from the previous quarter
The company's return on invested capital has surged by 50% YoY and by 24% QoQ
The ROE has grown by 7% from the previous quarter but it has contracted by 3.8% YoY
The ROA has grown by 6% from the previous quarter but it has contracted by 5% YoY

Dividends

What is BCYC's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for BCYC.

Financial health

How did BICYCLE THERAPEUTICS financials performed over time
The total liabilities has contracted by 41% YoY
BICYCLE THERAPEUTICS's total assets has decreased by 27% YoY and by 7% from the previous quarter
BCYC's debt is 97% smaller than its equity
BCYC's equity is down by 24% year-on-year and by 8% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.